Bako Diagnostics

What Bako Diagnostics does

Bako Diagnostics (BakoDx) is a specialized pathology laboratory providing diagnostic and therapeutic services focused on the skin, soft tissue, and bone of the lower extremity, headquartered at 6240 Shiloh Road in Alpharetta, Georgia. Founded in 2008 and operating with 251–500 employees, the company serves podiatric physicians, dermatologists, and infectious disease specialists through a unified portfolio that includes anatomic pathology (histopathology with PAS, GMS, and Fontana-Masson stains), molecular PCR testing (notably its proprietary Onychodystrophy PCR with Terbinafine Resistance panel covering 12 resistance mutations in four reactions), microbiology with Mass Spectrometry for organism identification, ENFD (Epidermal Nerve Fiber Density) immunohistochemistry for small fiber peripheral neuropathy diagnosis, and infectious disease NAAT testing for COVID-19 and Influenza A/B. The company differentiates its reporting through an "Intelligence Reporting" methodology that pairs diagnoses with treatment recommendations, disease background, and published literature references rather than delivering raw lab data.

Name

Bako Diagnostics

Legal name

Bako Diagnostics

Website

https://bakodx.com

Company type

Private

Founded year

2008

Operating status

Acquired

Headcount range

251–500 employees

Short description

Bako Diagnostics (BakoDx) is a specialized anatomic and molecular pathology laboratory providing diagnostic and therapeutic services for the skin, soft tissue, and bone of the lower extremity, serving podiatrists, dermatologists, and infectious disease specialists across the United States.

Ownership category

akta.pro rank

Product category

Diagnostic Pathology Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071)

akta.pro industry

PRIMARYHLAFAMAA

Anatomic Pathology (Histopathology & Cytopathology)

Healthcare & Life Sciences/Healthcare Providers & Systems/Clinical Laboratories

SECONDARYHLAKACAC

Dermatopathology

Healthcare & Life Sciences/Specialist Medical Practice/Dermatology

SECONDARYHLAGADAF

Molecular & Genetic Testing (PCR/NGS/qPCR)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Laboratory Testing & Analytical Services

SECONDARYHLAAALAI

Cytology & Histopathology Diagnostics (IHC, ISH, tissue-based assays)

Healthcare & Life Sciences/Biotechnology & Biologics/Diagnostics (Biotech-related)

Keywords

• Podiatric pathology services
• Anatomic pathology testing
• Molecular PCR diagnostics
• Dermatopathology laboratory
• Infectious disease testing

Headquarters

HQ city

Alpharetta

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Personnel, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Laboratory Testing Services: BakoDx provides diagnostic pathology and molecular testing services to physician offices. Services include anatomic pathology, clinical pathology, molecular PCR testing, microbiology, and specialized neurology testing. Revenue is generated through insurance billing (payor contracts) and direct patient payment for certain tests.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Bako Diagnostics is a specialty pathology laboratory providing anatomic pathology, molecular PCR testing, microbiology, and Epidermal Nerve Fiber Density (ENFD) analysis for podiatric physicians, dermatologists, and infectious disease specialists. Every test is delivered with the company's proprietary "intelligence reporting" methodology, which attaches structured treatment recommendations to the diagnostic interpretation.

Product overview

Bako Diagnostics operates as a specialized pathology laboratory focused on diagnostic and therapeutic services for the podiatric medical community, specializing in conditions affecting the skin, soft tissue, and bone of the lower extremity. The company offers a unified portfolio of diagnostic testing services centered around its core laboratory capabilities: anatomic pathology (histopathology with special stains), molecular diagnostics (PCR-based testing for onychodystrophy, skin infections, and terbinafine resistance), ENFD testing for neuropathy diagnosis, and infectious disease testing (COVID-19 and influenza). Supporting the testing services, BakoDx provides clinical therapeutic solutions (office-dispensed medications) and biopsy instruments/supplies for physician practices. The company also offers educational resources including webinars, instructional videos, and a mini-fellowship program. BakoDx was acquired by Fulgent Genetics in March 2026.

Differentiator

Problem solved

Functional benefit

Products and services

• Onychodystrophy PCR Testing with Terbinafine Resistance
• Anatomic Pathology Services
• Microbiology Testing Services
• ENFD (Epidermal Nerve Fiber Density) Testing
• BakoDx DermSTAT Skin Infection Test Suite
• Web Space Infection PCR Testing
• BakoID COVID-19 + Influenza A/B Testing
• Clinical Therapeutic Solutions (Physician-Dispensed Products)
• Biopsy Instruments & Specimen Supplies

Quantifiable outcome

• 24-hour in-house turnaround time for routine specimens
• +4 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• Fulgent GeneticscoreStrategic or Co-development Partner · 17 March 2026Fulgent Genetics completed the acquisition of Bako Diagnostics for approximately $56.9 million in cash (adjusted from initial announced price of $55.5 million). BakoDx became part of Fulgent Genetics' strategic vision to transform from a diagnostic business into a fully integrated precision medicine company. The acquisition expanded Fulgent's specialty laboratory testing capabilities into pathology services, and more than doubled its pathology sales team.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• PathGroup: Large US anatomic and clinical pathology services provider serving dermatologists, podiatrists, and other specialists with a similarly distributed field-sales model. Closest independent specialist-pathology comparable to BakoDx.
• StrataDx: Premier dermatopathology and anatomic pathology laboratory that was acquired by Fulgent Genetics together with Bako Diagnostics in March 2026. Directly comparable in scale, specialty focus, and go-to-market model — BakoDx's sister specialty lab inside the Fulgent portfolio.
• Inform Diagnostics (formerly AmeriPath / Quest Dermatopathology): Specialized dermatopathology and anatomic pathology laboratory with national reach serving dermatologists and podiatrists. Directly competitive with BakoDx in the dermatopathology/lower-extremity pathology niche.

Emerging players

• Castle Biosciences: Molecular diagnostics company focused on dermatologic and ophthalmic conditions (e.g., DecisionDx-Melanoma, DecisionDx-SCC). Comparable as a specialty dermatology-focused diagnostics company, though it primarily sells prognostic tests rather than pathology services.

Others

• Myriad Genetics: Molecular diagnostics company with specialty testing focus. Comparable on molecular diagnostic technology platform and payor-contracted revenue model, but operates in different clinical specialties (hereditary cancer, pharmacogenomics).

Broad incumbents

• Quest Diagnostics: Largest US reference laboratory offering anatomic pathology, molecular, and microbiology services across all specialties. Overlaps with BakoDx in dermatopathology and PCR testing but lacks Bako's exclusive podiatry focus.
• Sonic Healthcare USA: Global pathology and reference lab operator (parent of Aurora Diagnostics) with significant US anatomic pathology footprint serving dermatologists and other specialists.
• Laboratory Corporation of America (Labcorp): National reference laboratory providing dermatopathology, molecular diagnostics, and anatomic pathology services. Broad incumbent with overlapping capabilities but no specialist podiatry positioning.
• NeoGenomics Laboratories: Specialty oncology and molecular diagnostics laboratory serving oncologists and other specialists. Comparable as a US specialty reference lab with payor contracts and field sales force, though focused on oncology rather than podiatric pathology.
• ARUP Laboratories: Major academic-affiliated reference laboratory offering anatomic pathology and molecular diagnostics. Comparable on technology breadth and complexity but serves a different specialist mix than BakoDx.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/bakodiagnostics
• YouTubeyoutube.com/user/BakoPathology
• Facebookfacebook.com/BakoDiagnostics
• LinkedInlinkedin.com/company/bakodiagnostics

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bako Diagnostics